Cargando…

Exosomes as nanocarriers for siRNA delivery: paradigms and challenges

Exosomes are nano-sized vesicles that facilitate intercellular communications through carrying genetic materials and functional biomolecules. Owing to their unique size and structure, exosomes have emerged as a useful tool to overcome the limitations of siRNA delivery. The use of exosomes as siRNA d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shahabipour, Fahimeh, Banach, Maciej, Sahebkar, Amirhossein
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2016
Materias:	State of the Art Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108394/ https://www.ncbi.nlm.nih.gov/pubmed/27904525 http://dx.doi.org/10.5114/aoms.2016.62911

Ejemplares similares

The role of statins in lung cancer
por: Amin, Fatemeh, et al.
Publicado: (2021)

The effect of curcumin on hypoxia in the tumour microenvironment as a regulatory factor in cancer
por: Zahedi, Mohammad, et al.
Publicado: (2023)

The effects of statins on the function and differentiation of blood cells
por: Chamani, Sajjad, et al.
Publicado: (2022)

The role of nutraceuticals in heart failure muscle wasting as a result of inflammatory activity. The International Lipid Expert Panel (ILEP) Position Paper
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2023)

Nanocarriers for delivery of siRNA as gene silencing mediator
por: Morales-Becerril, Aideé, et al.
Publicado: (2022)

Subfractions of high-density lipoprotein (HDL) and dysfunctional HDL in chronic kidney disease patients
por: Rysz-Górzyńska, Magdalena, et al.
Publicado: (2016)

On the present and future role of Lp-PLA(2) in atherosclerosis-related cardiovascular risk prediction and management
por: Fras, Zlatko, et al.
Publicado: (2020)

2023: The year in cardiovascular disease – the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024?
por: Banach, Maciej, et al.
Publicado: (2023)

Resveratrol and cognitive decline: a clinician perspective
por: Cicero, Arrigo F.G., et al.
Publicado: (2019)

Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease
por: Franczyk-Skóra, Beata, et al.
Publicado: (2013)

Lipids, blood pressure, kidney – what was new in 2011?
por: Barylski, Marcin, et al.
Publicado: (2011)

Menopause and women’s cardiovascular health: is it really an obvious relationship?
por: Ryczkowska, Kamila, et al.
Publicado: (2022)

Preparation of Exosomes for siRNA Delivery to Cancer Cells
por: Faruqu, Farid N., et al.
Publicado: (2018)

Strategies for ocular siRNA delivery: Potential and limitations of non-viral nanocarriers
por: Thakur, Ajit, et al.
Publicado: (2012)

Modular Plasmonic Nanocarriers for Efficient and Targeted Delivery of Cancer-Therapeutic siRNA
por: Huang, Xiao, et al.
Publicado: (2014)

Nanomaterials-Based siRNA Delivery: Routes of Administration, Hurdles and Role of Nanocarriers
por: Gupta, Nitin, et al.
Publicado: (2019)

A Multifunctional Hybrid Nanocarrier for Non-Invasive siRNA Delivery to the Retina
por: Nishida, Shogo, et al.
Publicado: (2023)

High-Capacity Mesoporous Silica Nanocarriers of siRNA for Applications in Retinal Delivery
por: Ultimo, Amelia, et al.
Publicado: (2023)

siRNA Therapeutics: Future Promise for Neurodegenerative Diseases
por: Amiri, Atefeh, et al.
Publicado: (2021)

Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology
por: Anker, Markus S., et al.
Publicado: (2013)

Molecular mechanisms of statin intolerance
por: Gluba-Brzozka, Anna, et al.
Publicado: (2016)

The pH-Triggered Triblock Nanocarrier Enabled Highly Efficient siRNA Delivery for Cancer Therapy
por: Du, Lili, et al.
Publicado: (2017)

The influence of hypoxic physical activity on cfDNA as a new marker of vascular inflammation
por: Pokrywka, Andrzej, et al.
Publicado: (2015)

Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview
por: Michalska-Kasiczak, Marta, et al.
Publicado: (2018)

Non-alcoholic fatty liver disease, metabolic syndrome, and type 2 diabetes mellitus: where do we stand today?
por: Mitrovic, Bojan, et al.
Publicado: (2022)

Poly(amidoamine) Dendrimer Nanocarriers and Their Aerosol Formulations for siRNA Delivery to the Lung Epithelium
por: Conti, Denise S., et al.
Publicado: (2014)

Natural Polysaccharides for siRNA Delivery: Nanocarriers Based on Chitosan, Hyaluronic Acid, and Their Derivatives
por: Serrano-Sevilla, Inés, et al.
Publicado: (2019)

Non-Cationic RGD-Containing Protein Nanocarrier for Tumor-Targeted siRNA Delivery
por: Yu, Xiaolin, et al.
Publicado: (2021)

Opportunities and challenges in psychopharmacology 
por: Schulz, Pierre
Publicado: (2019)

Game of “crowning” season 8: RAS and reproductive hormones in COVID-19 – can we end this viral series?
por: Cismaru, Andrei Cosmin, et al.
Publicado: (2020)

Brome mosaic virus-like particles as siRNA nanocarriers for biomedical purposes
por: Nuñez-Rivera, Alfredo, et al.
Publicado: (2020)

Genetic variation and pharmacogenomics: concepts, facts, and challenges
por: Hoehe, Margret R., et al.
Publicado: (2004)

Pharmacological approaches to the challenge of treatment-resistant depression
por: Ionescu, Dawn F., et al.
Publicado: (2015)

Classification of autism and related conditions: progress, challenges, and opportunities
por: Volkmar, Fred R., et al.
Publicado: (2012)

A Fresh Look at the Potential of Cyclodextrins for Improving the Delivery of siRNA Encapsulated in Liposome Nanocarriers
por: Castillo Cruz, Betzaida, et al.
Publicado: (2022)

Dual Tumor-Targeting Nanocarrier System for siRNA Delivery Based on pRNA and Modified Chitosan
por: Li, Lin, et al.
Publicado: (2017)

lncRNA/MicroRNA interactions in the vasculature
por: Ballantyne, MD, et al.
Publicado: (2016)

A New Era in Cardiac Rehabilitation Delivery: Research Gaps, Questions, Strategies, and Priorities
por: Beatty, Alexis L., et al.
Publicado: (2023)

New paradigms on siRNA local application
por: Pan, Meng, et al.
Publicado: (2015)

A Light-Driven Therapy of Pancreatic Adenocarcinoma Using Gold Nanorods-Based Nanocarriers for Co-Delivery of Doxorubicin and siRNA
por: Yin, Feng, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_59ackb0o1udolo37u1das4p76h